- Report
- August 2022
- 118 Pages
Global
From €4322EUR$4,500USD£3,721GBP
- Report
- April 2018
Global
From €4322EUR$4,500USD£3,721GBP
- Report
- September 2021
- 111 Pages
Global
From €4322EUR$4,500USD£3,721GBP
- Report
- July 2022
- 40 Pages
China
From €3073EUR$3,200USD£2,646GBP
- Report
- August 2018
- 37 Pages
Global
From €9605EUR$10,000USD£8,269GBP
- Drug Pipelines
- July 2018
- 393 Pages
Global
From €21130EUR$22,000USD£18,192GBP
- Report
- May 2018
- 55 Pages
Global
From €9605EUR$10,000USD£8,269GBP
- Report
- March 2018
- 204 Pages
Global
From €7203EUR$7,500USD£6,202GBP
- Report
- June 2021
Global
From €10560EUR$10,995USD£9,092GBP
- Report
- September 2020
- 148 Pages
Global
From €10560EUR$10,995USD£9,092GBP
- Report
- October 2019
- 128 Pages
Global
From €10560EUR$10,995USD£9,092GBP
- Report
- December 2018
- 48 Pages
Global
From €3357EUR$3,495USD£2,890GBP
- Report
- September 2020
- 65 Pages
Global
€1266EUR$1,318USD£1,090GBP
- Report
- August 2018
- 679 Pages
Global
From €21130EUR$22,000USD£18,192GBP
- Report
- April 2022
- 188 Pages
Global
From €3458EUR$3,600USD£2,977GBP
- Report
- October 2018
- 50 Pages
Global
From €8159EUR$8,495USD£7,024GBP
- Report
- September 2018
- 132 Pages
Global
From €5763EUR$6,000USD£4,961GBP
- Drug Pipelines
- March 2023
- 125 Pages
Global
From €10560EUR$10,995USD£9,092GBP
- Report
- April 2023
- 113 Pages
Global
€3362EUR$3,500USD£2,894GBP
- Report
- April 2018
United States
From €7679EUR$7,995USD£6,611GBP
Remicade is a biologic drug used to treat immune disorders such as Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis. It is a monoclonal antibody that works by blocking the action of tumor necrosis factor (TNF), a protein that plays a role in inflammation. Remicade is administered intravenously and is usually given in a series of three infusions over a period of several weeks.
Remicade is a major player in the immune disorders drugs market, with a wide range of indications and a long track record of safety and efficacy. It is one of the most widely prescribed biologic drugs in the world, and is used by millions of patients.
Companies in the Remicade market include Johnson & Johnson, Merck, Pfizer, AbbVie, and Amgen. Show Less Read more